Cytokines and their receptors in cardiovascular diseases - Role of gp130 signalling pathway in cardiac myocyte growth and maintenance

International Journal of Experimental Pathology

Volumn 81, Issue 1, 2000, Pages 1-16

  Yamauchi Takihara, K ^a   Kishimoto, T ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Apoptosis; Cardiac myocytes; Cardiotrophin 1; Cytoprotection; gp130; Hypertrophy; JAK STAT

Indexed keywords

ANGIOTENSIN; CARDIOTROPHIN 1; CYTOKINE; GLYCOPROTEIN GP 130; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; LEUKEMIA INHIBITORY FACTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BCL X; STAT3 PROTEIN;

ACUTE HEART INFARCTION; APOPTOSIS; CARDIOVASCULAR DISEASE; CELL PROTECTION; HEART FAILURE; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TRANSACTIVATION; TRANSGENIC MOUSE;

ANIMALS; CARDIOVASCULAR DISEASES; CYTOKINES; HUMANS; INTERLEUKIN-6; MICE; MICE, TRANSGENIC; RECEPTORS, GROWTH FACTOR; SIGNAL TRANSDUCTION;

EID: 0034021317     PISSN: 09599673     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2613.2000.00139.x     Document Type: Review

References (127)

1. AKIRA S., ISSHIKI H., SUGITA T. et al. (1990) A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. EMBO J. 9, 1897-1906.
2. ANVERSA P., RICCI R. & OLIVETTI G. (1986) Quantitative structural analysis of the myocardium during physiologic growth and induced cardiac hypertrophy. J. Am. Coll. Cardiol. 7, 1140-1149.
3. AUKRUST P., UELAND T., LIEN E. et al. (1999) Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am. J. Cardiol. 83, 376-382.
4. BAKER K.M. & ACETO J.F. (1990) Angiotensin II stimulation of protein synthesis and cell growth in chick heart cells. Am. J. Physiol. 259, H610-H618.
5. BHAT G.J., ABRAHAM S.T. & BAKER K.M. (1996) Angiotensin II interferes with interleukin 6-induced Stat3 signaling by a pathway involving mitogen-activated protein kinase kinase 1. J. Biol. Chem. 271, 22447-22452.
6. BIALIK S., GEENEN D.L., SASSON I.E. et al. (1997) Myocyte apoptosis during acute myocardial infarction in the mouse localizes to hypoxic regions but occurs independently of p53. J. Clin. Invest. 100, 1363-1372.
7. BOISE L.H., GONZALEZ-GARCIA M., POSTEMA C.E. et al. (1993) bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74, 597-608.
8. BURGERING B.M. & COFFER P.J. (1995) Protein kinase B (c-Akt) in phosphatidyl-inositol-3-OH kinase signal transduction. Nature 376, 599-602.
9. BUZDAR A.U., MARCUS C., SMITH T.L. & BLUMENSCHEIN G.R. (1985) Early and delayed clinical cardiotoxicity of doxorubicin. Cancer 55, 2761-2765.
10. BETZ U.A.K., BLOCH W., BROEK M. et al. (1998) Postnatally induced inactivation of gp130 in mice results in neurological, cardiac, hematopoietic, immunological, hepatic, and pulmonary defects. J. Exp. Med. 188, 1955-1965.
11. CHANDRASEKAR B., MITCHELL D.H., COLSTON J.T. & FREEMAN G.L. (1999) Regulation of CCAAT/Enhancer binding protein, interleukin-6, interleukin-6 receptor, and gp130 expression during myocardial ischemia/reperfusion. Circulation 99, 427-433.
12. CHUNG J., GRAMMER T.C., LEMON K.P., KAZLAUSKAS A. & BLENIS J. (1994) PDGF-and insulin-dependent p70 S6K activation mediated by phosphatidylinositol-3-OH kinase. Nature 370, 71-75.
13. CITTADINI A., STROMER H., KATZ S.E. et al. (1996) Differential cardiac effects of growth hormone and insulin-like growth factor-1 in the rat. A combined in vivo and in vitro evaluation. Circulation 93, 800-809.
14. DAVIS R.J. (1993) The mitogen-activated protein kinase signal transduction pathway. J. Biol. Chem. 268, 14553-14556.
15. DREXLER H., HANZE J., FINCKH M., LU W., JUST H. & LANG R.E. (1989) Atrial natriuretic peptide in a rat model of cardiac failure. Circulation 79, 620-633.
16. DUDEK H., DATTA S.R., FRANKE T.F. et al. (1997) Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 275, 661-664.
17. DUERR R.L., HUANG S., MIRALIAKBAR H.R., CLARK R., CHIEN K.R. & ROSS J. JR (1995) Insulin-like growth factor-1 enhances ventricular hypertrophy and function during the onset of experimental cardiac failure. J. Clin. Invest. 95, 619-627.
18. ENDO-TAKAHO A., MASUHARA M., YOKOUCHI M. et al. (1997) A new protein containing an SH2 domain that inhibits JAK kinases. Nature 387, 921-924.
19. FELDMAN A.M., WEINBERG E.O., RAY P.E. & LORELL B.H. (1993) Selective changes in cardiac gene expression during compensated hypertrophy and the transition to cardiac decompensation in rats with chronic aortic banding. Circ. Res. 73, 184-192.
20. FERRARI R., BACHETTI T., CONFORTINI R. et al. (1995) Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. Circulation 92, 1479-1486.
21. FINKEL M.S., ODDIS C.V., JACOB T.D., WATKINS S.C., HATTLER B.G. & SIMMONS R.L. (1992) Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 257, 387-389.
22. FONCEA R., ANDERSSON M., KETTERMAN A. et al. (1997) Insulin-like growth factor-1 rapidly activates multiple signal transduction pathways in cultured rat cardiac myocytes. J. Biol. Chem. 272, 19115-19124.
23. FUJIO Y., KUNISADA K., HIROTA H., YAMAUCHI-TAKIHARA K. & KISHIMOTO T. (1997) Signals through gp130 upregulate bcl-x gene expression via STAT1-binding cis-element in cardiac myocytes. J. Clin. Invest. 99, 2898-2905.
24. GOLD M.R., DURONIO V., SAXENA S.P., SCHRADER J.W. & AEBERSOLD R. (1994) Multiple cytokines activate phosphatidylinositol 3-kinase in hemopoietic cells. J. Biol. Chem. 269, 5403-5412.
25. GOTTLIEB R.A., BURLESON K.O., KLONER R.A., BABIOR B.M. & ENGLER R.L. (1994) Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J. Clin. Invest. 94, 1621-1628.
26. GWECHENBERGER M., MENDOZA L.H., YOUKER K.A. et al. (1999) Cardiac myocytes produce interleukin-6 in culture and in viable border zone of reperfused infarctions. Circulation 99, 546-551.
27. HILTON D.J. (1992) LIF: lots of interesting functions. Trends Biochem. Sci. 17, 72-76.
28. HIRANO T., NAKAJIMA K. & HIBI M. (1997) Signaling mechanisms through gp130: a model of the cytokine system. Cytokine Growth Factor Rev. 8, 241-252.
29. HIROTA H., CHEN J., BETZ U.A. et al. (1999) Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress. Cell 97, 189-198.
30. HIROTA H., YOSHIDA K., KISHIMOTO T. & TAGA T. (1995) Continuous activation of gp130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice. Proc. Natl. Acad. Sci. USA 92, 4862-4866.
31. HIROTA H., YOSHIDA K., TAGA T. & KISHIMOTO T. (1996) gp130 signaling pathways: recent advances and implications for cardiovascular disease. Trends Cardiovasc. Med. 6, 109-115.
32. HISHINUMA S., FUNAMOTO M., FUJIO Y., KUNISADA K. & YAMAUCHI-TAKIHARA K. (1999) Hypoxic strress induces cardiotrophin-1 expression in cardiac myocytes. Biochem. Biophys. Res. Commun. 264, 436-440.
33. HUBER S.A., POLGAR J., SCHULTHEISS P. & SCHWIMMBECK P. (1994) Augmentation of pathogenesis of coxsackievirus B3 infections in mice by exogenous administration of interleukin-1 and interleukin-2. J. Virol. 68, 195-206.
34. IP N.Y. & YANCOPOULOS G.D. (1996) The neurotrophins and CNTF: two families of collaborative neurotrophic factors. Annu. Rev. Neurosci. 19, 491-515.
35. ISHIKAWA M., SAITO Y., MIYAMOTO Y. et al. (1996) cDNA cloning of rat cardiotrophin-1 (CT-1): augmented expression of CT-1 gene in ventricle of genetically hypertensive rats. Biochem. Biophys. Res. Commun. 219, 377-381.
36. ISSHIKI H., AKIRA S., TANABE O. et al. (1990) Constitutive and interleukin-1 (IL-1)-inducible factors interact with the IL-1-responsive element in the IL-6 gene. Mol. Cell Biol. 10, 2757-2764.
37. ITO H., HIRATA Y., HIROE M. et al. (1991) Endothelin-1 induces hypertrophy with enhanced expression of muscle-specific genes in cultured neonatal rat cardiomyocytes. Circ. Res. 69, 209-215.
38. ITO H., MILLER S.C., BILLINGHAM M.E. et al. (1990) Doxorubicin selectively inhibits muscle gene expression in cardiac muscle cells in vivo and in vitro. Proc. Natl. Acad. Sci. USA 87, 4275-4279.
39. ITOH G., TAMURA J., SUZUKI M. et al. (1995) DNA fragmentation of human infarcted myocardial cells demonstrated by the nick end labeling method and DNA agarose gel electrophoresis. Am. J. Patholl. 146, 1325-1331.
40. JEYASEELAN R., POIZAT C., WU H.Y. & KEDES, L. (1997) Molecular mechanisms of doxorubicin-induced cardiomyopathy. J. Biol. Chem. 272, 5828-5832.
41. KAJSTURA J., CHENG W., REISS K. et al. (1996) Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab. Invest. 74, 86-107.
42. KAJSTURA J., CIGOLA E., MALHOTRA A. et al. (1997) Angiotensin II induces apoptosis of adult ventricular myocytes in vitro. J. Mol. Cell. Cardiol. 29, 859-870.
43. KANDA T., MCMANUS J.E., NAGAI R. et al. (1996) Modification of viral myocarditis in mice by interleukin-6. Circ. Res. 78, 848-856.
44. KARAKURUM M., SHREENIWAS R., CHEN J. et al. (1994) Hypoxic induction of interleukin-8 gene expression in human endothelial cells. J. Clin. Invest. 93, 1564-1570.
45. KELLY R.A. & SMITH T.W. (1997) Cytokines and cardiac contractile function. Circulation 95, 778-781.
46. KISHIMOTO T., AKIRA S., NARAZAKI M. & TAGA T. (1995) Interleukin-6 family of cytokines and gp130. Blood 86, 1243-1254.
47. KISHIMOTO T., TAGA T. & AKIRA S. (1994) Cytokine signal transduction. Cell 76, 253-262.
48. KODAMA H., FUKUDA K., PAN J. et al. (1998) Biphasic activation of the JAK/STAT pathway by angiotensin II in rat cardiomyocytes. Circ. Res. 82, 244-250.
49. KOHN A.D., KOVACINA K.S. & ROTH R.A. (1995) Insulin stimulates the kinase activity of RAC-PK, a pleckstrin homology domain containing ser/thr kinase. EMBO J. 14, 4288-4295.
50. KOMUHO I., KAIDA T., SHIBAZAKI Y. et al. (1990) Stretching cardiac myocytes stimulates protooncogene expression. J. Biol. Chem. 265, 3595-3598.
51. KOMURO I. & YAZAKI Y. (1993) Control of cardiac gene expression by mechanical stress. Annu. Rev. Physiol. 55, 55-75.
52. KULIK G., KLIPPEL A. & WEBER M.J. (1997) Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt. Mol. Cell. Biol. 17, 1595-1606.
53. KUNISADA K., HIROTA H., FUJIO Y. et al. (1996) Activation of JAK-STAT and MAP kinases by leukemia inhibitory factor through gp130 in cardiac myocytes. Circulation 94, 2626-2632.
54. KUNISADA K., NEGORO S., TONE E., FUNAMOTO M. & YAMAUCHI-TAKIHARA K. (2000) STAT3 in the heart transduces not only a hypertrophic signal but a protective signal against doxorubicin-induced cardiomyopathy. Proc. Natl. Acad. Sci. USA, 97, 315-319.
55. KUNISADA K., TONE E., FUJIO Y., MATSUI H., YAMAUCHI-TAKIHARA K. & KISHIMOTO T. (1998) Activation of gp130 transduces hypertrophic signals via STAT3 in cardiac myocytes. Circulation 98, 346-352.
56. LENARDO M.J. & BALTIMORE D. (1989) NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control. Cell 58, 227-229.
57. LEVINE B., KALMAN J., MAYER L., FILLIT H.M. & PACKER M. (1990) Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N. Engl. J. Med. 323, 236-241.
58. LEVY D., GARRISON R.J., SAVAGE D.D., KANNEL W.B. & CASTELLI W.P. (1990) Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N. Engl. J. Med. 322, 1561-1566.
59. LI M., SENDTNER M. & SMITH A. (1995) Essential function of LIF receptor in motor neurons. Nature 378, 724-727.
60. MACGOWAN G.A., MANN D.L., KORMOS R.L., FELDMAN A.M. & MURALI S. (1997) Circulating interleukin-6 in severe heart failure. Am. J. Cardiol. 79, 1128-1131.
61. MANN D.L., KENT R.L. & COOPER G.T. (1989) Load regulation of the properties of adult feline cardiocytes: growth induction by cellular deformation. Circ. Res. 64, 1079-1090.
62. MATSUI H., FUJIO Y., KUNISADA K., HIROTA H. & YAMAUCHI-TAKIHARA K. (1996) Leukemia inhibitory factor induces a hypertrophic response mediated by gp130 in murine cardiac myocytes. Res. Commun. Mol. Pathol. Pharmacoll. 93, 149-162.
63. MATSUI H., IHARA Y., FUJIO Y. et al. (1999) Induction of interleukin (IL) -6 by hypoxia is mediated by nuclear factor (NF) -kappa B and NF-IL6 in cardiac myocytes. Cardiovasc. Res. 42, 104-112.
64. MATSUMORI A., YAMADA T., SUZUKI H., MATOBA Y. & SASAYAMA S. (1994) Increased circulating cytokines in patients with myocarditis and cardiomyopathy. Br. Heart J. 72, 561-566.
65. MATSUSAKA T., FUJIKAWA K., NISHIO Y. et al. (1993) Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc. Natl. Acad. Sci. USA 90, 10193-10197.
66. MCWHINNEY C.D., HUNT R.A., CONRAD K.M., DOSTAL D.E. & BAKER K.M. (1997) The type I angiotensin II receptor couples to Stat1 and Stat3 activation through Jak2 kinase in neonatal rat cardiac myocytes. J. Mol. Cell. Cardiol. 29, 2513-2524.
67. MESTAN J., DIGEL W., MITTNACHT S. et al. (1986) Antiviral effects of recombinant tumour necrosis factor in vitro. Nature 323, 816-819.
68. MIYAO Y., YASUE H., OGAWA H. et al. (1993) Elevated plasma interleukin-6 levels in patients with acute myocardial infarction. Am. Heart J. 126, 1299-1304.
69. MURAKAMI M., HIBI M., NAKAGAWA N. et al. (1993) IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase. Science 260, 1808-1810.
70. NAKA T., NARAZAKI M., HIRATA M. et al. (1997) Structure and function of a new STAT-induced STAT inhibitor. Nature 387, 924-929.
71. NEGORO S., KUNISADA K., TONE E., FUNAMOTO M. & YAMAUCHI-TAKIHARA K. (1999) Activation of JAK/STAT pathway transduces cytoprotective signals in rat acute myocardial infarction. Circulation 100, 1-491.
72. NOZAKI N., YAMAGUCHI S., YAMAOKA M., OKUYAMA M., NAKAMURA H. & TOMOIKE H. (1997) Soluble tumor necrosis factor soluble receptors are elevated in relation to severity of congestive heart failure. Jpn. Circ. J. 61, 657-664.
73. OH H., FUJIO Y., KUNISADA K. et al. (1998a) Activation of phosphatidylinositol 3-kinase through glycoprotein 130 induces protein kinase B and p70, S6 kinase phosphorylation in cardiac myocytes. J. Biol. Chem. 273, 9703-9710.
74. OH H., KUNISADA K., FUNAMOTO M., NEGORO S. & YAMAUCHI-TAKIHARA K. (1998b) Activation of gp130 inhibits doxorubicin induced cell death by bcl-xL/caspase-3 interaction and P13-kinase/Akt pathway in cardiac myocytes. Circulation 98, 1-462.
75. OLIVETTI G., QUAINI F., SALA R. et al. (1996) Acute myocardial infarction in humans is associated with activation of programmed myocyte cell death in the surviving portion of the heart. J. Mol. Cell. Cardiol. 28, 2005-2016.
76. ONO K., MATSUMORI A., SHIOI T., FURUKAWA Y. & SASAYAMA S. (1998) Cytokine gene expression after myocardial infarction in rat hearts. Circulation 98, 149-156.
77. PACKER M. (1992) The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. J. Am. Coll. Cardiol. 20, 248-254.
78. PAN J., FUKUDA K., KODAMA H. et al. (1997) Role of angiotensin II in activation of the JAK/STAT pathway induced by acute pressure overload in the rat heart. Circ. Res. 81, 611-617.
79. PAN J., FUKUDA K., SAITO M. et al. (1999) Mechanical stretch activates the JAK/STAT pathway in rat cardiomyocytes. Circ. Res. 84, 1127-1136.
80. PATTERSON P.H. & NAWA H. (1993) Neuronal differentiation factors/cytokines and synaptic plasticity. Cell 72, 123-137.
81. PENNICA D., KING K.L., SHAW K.J. et al. (1995a) Expression cloning of cardiotrophin 1, a cytokine that induces cardiac myocyte hypertrophy. Proc. Natil. Acad. Sci. USA 92, 1142-1146.
82. PENNICA D., SHAW K.J., SWANSON T.A. et al. (1995b) Cardiotrophin-1: biological activities and binding to the leukemia inhibitory factor receptor/gp130 signaling complex. J. Biol. Chem. 270, 10915-10922.
83. PENNICA D., ARCE V., SWANSON T.A. et al. (1996a) Cardiotrophin-1, a cytokine present in embryonic muscle, supports long-term survival of spinal motoneurons. Neuron 17, 63-74.
84. PENNICA D., SWANSON T.A., SHAW K.J. et al. (1996b) Human cardiotrophin-1: protein and gene structure, biological and binding activities, and chromosomal localization. Cytokine 8, 183-189.
85. PESO L., GONZALEZ-GARCIA M., PAGE C., HERRERA R. & NUNEZ G. (1997) Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 278, 687-689.
86. POST G.R., GOLDSTEIN D., THUERAUF D.J., GLEMBOTSKI C.C. & BROWN J.H. (1996) Dissociation of p44 and p42 mitogen-activated protein kinase activation from receptor-induced hypertrophy in neonatal rat ventricular myocytes. J. Biol. Chem. 271, 8452-8457.
87. REIF K., BURGERING B.M. & CANTRELL D.A. (1997) Phosphatidylinositol 3-kinase links the interleukin-2 receptor to protein kinase B and p70, S6 kinase. J. Biol. Chem. 272, 14426-14433.
88. ROOK A.M., MASUR H., LANE H.C. et al. (1983) Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome. J. Clin. Invest. 72, 398-403.
89. SADOSHIMA J. & IZUMO S. (1993) Mechanical stretch rapidly activates multiple signal transduction pathways in cardiac myocytes: potential involvement of an autocrine/paracrine mechanism. EMBO J. 12, 1681-1692.
90. SADOSHIMA J., XU Y., SLAYTER H.S. & IZUMO S. (1993) Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell 75, 977-984.
91. SAITO M., YOSHIDA K., HIBI M., TAGA T. & KISHIMOTO T. (1992) Molecular cloning of a murine IL-6 receptor-associated signal transducer, gp130, and its regulated expression in vivo. J. Immunol. 148, 4066-4071
92. SAWARD L. & ZAHRADKA P. (1997) Angiotensin II activates phosphatidylinositol 3-kinase in vascular smooth muscle cells. Circ. Res. 81, 249-257.
93. SCHEID M.P. & DURONIO V. (1998) Dissociation of cytokine-induced phosphorylation of Bad and activation of PKB/Akt: Involvement of MEK upstream of Bad phosphorylation. Proc. Natl. Acad. Sci. USA 95, 7439-7444.
94. SCHWARZE M.M.K. & HAWLEY R.G. (1995) Prevention of myeloma cell apoptosis by ectopic bcl-2 expression or interleukin 6-mediated up-regulation of bcl-xL. Cancer Res. 55, 2262-2265.
95. SENDTNER M., KREUTZBERG G.W. & THOENEN H. (1990) Ciliary neurotrophic factor prevents the degeneration of motor neurons after axotomy. Nature 345, 440-441.
96. SHIOI T., MATSUMORI A. & SASAYAMA S. (1996) Persistent expression of cytokine in the chronic stage of viral myocarditis in mice. Circulation 94, 1930-1937.
97. SHUBEITA H.E., MCDONOUGH P.M., HARRIS A.N. et al. (1990) Endothelin induction of inositol phospholipid hydrolysis, sarcomere assembly, and cardiac gene expression in ventricular myocytes. J. Biol. Chem. 265, 20555-20562.
98. SIMPSON P. (1985) Stimulation of hypertrophy of cultured neonatal rat heart cells through an alpha 1-adrenergic receptor and induction of beating through an alpha 1-and beta 1-adrenergic receptor interaction. Circ. Res. 56, 884-894.
99. STARR R., WILLSON T.A., VINEY E.M. et al. (1997) A family of cytokine-inducible inhibitors of signaling. Nature 387, 917-921.
100. SUEMATSU S., MATSUDA T., AOZASA K. et al. (1989) IgG1 plasmacytosis in interleukin 6 transgenic mice. Proc. Natl. Acad. Sci. USA 86, 7547-7550.
101. TANAKA M., ITO H., ADACHI S. et al. (1994) Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes. Circ. Res. 75, 426-433.
102. TANAKA N., RYOKE T., HONGO M. et al. (1998) Effects of growth hormone and IGF-1 on cardiac hypertrophy and gene expression in mice. Am. J. Physiol. 275, H393-H399.
103. TEIGER E., THAN V.D., RICHARD L. et al. (1996) Apoptosis in pressure overload-induced heart hypertrophy in the rat. J. Clin. Invest. 97, 2891-2897.
104. THAIK C.M., CALDERONE A., TAKAHASHI N. & COLUCCI W.S. (1995) Interleukin-1b modulates the growth and phenotype of neonatal rat cardiac myocytes. J. Clin. Invest. 96, 1093-1099.
105. THORBURN J., CARLSON M., MANSOUR S.J., CHIEN K.R., AHN N.G. & THORBURN A. (1995) Inhibition of a signaling pathway in cardiac muscle cells by ative mitogen-activated protein kinase kinase. Mol. Biol. Cell 6, 1479-1490.
106. THORBURN J., FROST J.A. & THORBURN A. (1994) Mitogen-activated protein kinases mediate changes in gene expression, but not cytoskeletal organization associated with cardiac muscle cell hypertrophy. J. Cell Biol. 126, 1565-1572.
107. TONE E., KUNISADA K., FUJIO Y. et al. (1998) Angiotensin II interferes with leukemia inhibitory factor-induced STAT3 activation in cardiac myocytes. Biochem. Biophys. Res. Commun. 253, 147-150.
108. TORRE-AMIONE G., KAPADIA S., BENEDICT C., ORAL H., YOUNG J.B. & MANN D.L. (1996) Proinflammatory cylokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). J. Am. Coll. Cardiol. 27, 1201-1206.
109. VEJSADA R., SAGOT Y. & KATO A.C. (1995) Quantitative comparison of the transient rescue effects of neurotrophic factors on axotomized motoneurons in vivo. Eur. J. Neurosci. 7, 108-115.
110. WARE B.W., HOROWITS M.C., RENSHAW B.R. et al. (1995) Targeted disruption of the low-affinity leukemia inhibitory factor receptor causes placental, skeletal, neural and metabolic defects and results in perinatal death. Development 121, 1283-1299.
111. WEBSTER K.A., DISCHER D.J. & BISHOPRIC N.H. (1993) Induction and nuclear accumulation of fos and jun proto-oncogenes in hypoxic cardiac myocytes. J. Biol. Chem. 268, 16852-16858.
112. WEISSENBACH J., CHERNAJOVSKY Y., ZEEVI M. et al. (1980) Two Interferon mRNAs in human fibroblasts: in vitro translation and Escherichia coli cloning studies. Proc. Natl. Acad. Sci. USA 77, 7152-7156.
113. WEN Z., ZHONG Z. & DARNELL J.E. JR (1995) Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 82, 241-250.
114. WOLLERT K.C., TAGA T., SAITO M. et al. (1996) Cardiotrophin-1 activates a distinct form of cardiac muscle cell hypertrophy. J. Biol. Chem. 271, 9535-9345.
115. WOLLERT K.C. & CHIEN K.R. (1997) Cardiotrophin-1 and the role of gp130-dependent signaling pathways in cardiac growth and development. J. Mol. Med. 75, 492-501.
116. YAMADA T., MATSUMORI A. & SASAYAMA S. (1994) Therapeutic effect of anti-tumor necrosis factor-alpha antibody on the murine model of viral myocarditis induced by encephalomyocarditis virus. Circulation 89, 846-851.
117. YAMAUCHI-TAKIHARA K., IHARA Y., OGATA A., YOSHIZAKI K., AZUMA J. & KISHIMOTO T. (1995a) Hypoxic stress induced cardiac myocyte derived interleukin-6. Circulation 91, 1520-1524.
118. YAMAUCHI-TAKIHARA K., IHARA Y., YOSHIZAKI K. & KISHIMOTO T. (1995b) Hypoxic stress induced cardiac myocyte derived interleukin-6. - Activation of IL-6 is mediated by NF-IL6 and NF-Kb binding sites - In Cardiac Development and Gene Regulation (Ed. Y. YAZAKI.) Tokyo: Excerpta Medica Ltd, pp. 111-126.
119. YAMAZAKI T., KOMURO I., KUDOH S. et al. (1995) Angiotensin II partly mediates mechanical stress-induced cardiac hypertrophy. Circ. Res. 77, 258-265.
120. YAMAZAKI T., KOMURO I., KUDOH S. et al. (1996) Endothelin-1 is involved in mechanical stress-induced cardiomyocyte hypertrophy. J. Biol. Chem. 271, 3221-3228.
121. YAN S.F., TRITTO I., PINSKY D. et al. (1995) Induction of interleukin-6 (IL-6) by hypoxia in vascular cells. J. Biol. Chem. 270, 11463-11471.
122. YANG Y.C. (1993) Interleukin 11: an overview. Stem Cells 11, 474-486.
123. YANG E., ZHA J., JOCKEL J., BOISE L.H., THOMPSON C.B. & KORSMEYER S.J. (1995) Bad, a heterodimeric partner for Bcl-xL and Bcl-2, displaces Bax and promotes cell death. Cell 80, 285-291.
124. YAO R. & COOPER G.M. (1995) Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. Science 267, 2003-2006.
125. YOSHIDA K., TAGA T., SAITO M. et al. (1996) Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders. Proc. Natl. Acad. Sci. USA 93, 407-411.
126. YOSHIMURA A., OHKUBO T., KIGUCHI T. et al. (1995) A novel cytokine-inducible gene CIS encodes an SH2-containing protein that binds to tyrosine-phosphorylated interleukin 3 and erythropoietin receptors. EMBO J. 14, 2816-2826.
127. ZHANG X., BLENIS J., LI H.C., SCHINDLER C. & CHEN-KIANG S. (1995) Requirement of serine phosphorylation for formation of STAT-promoter complexes. Science 267, 1990-1994.